Open
Closing Soon
Team Grant: ERDERA Joint Transnational Call 2026
International rare disease research funding
Last Update: April 21, 2026
Funding available
$ 450,000
Timeline
- Closing date : July 8, 2026
Location
Canada
Overview
This program supports international research on unresolved rare genetic and non-genetic diseases. The maximum funding is CAD 450,000 per grant for up to 3 years, and eligible activities include collaborative diagnostic research, data analysis, and related project work.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop team skills
- Increase social or community impact
Eligible Funding
- Maximum amount : 450,000 $
Timeline
- Closing date : July 8, 2026
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
- Health care and social assistance
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Diagnostic research on unresolved rare genetic diseases
- Research on complex rare non-genetic diseases
- Identification of causative variants in undiagnosed cases
- Use of multi-omics, bioinformatics, AI, and systems biology approaches
Documents Needed
- CVs for participants, except collaborators
- Research proposal summary
- Budget information and justification
- Attestation form for sensitive technology research, if applicable
- Signed proposal signature pages and routing slip
Official resources
Eligibility
Who is eligible?
- Universities and research institutes
- Hospitals and public health institutions
- Private companies
- Patient advocacy organisations
Who is not eligible
- Groups outside the participating countries
- Applicants under excluded national rules
- PAOs where national rules do not allow funding
- Organizations listed as ineligible by a national funder
Eligible expenses
- Personnel costs for project work
- Consumables and materials
- Travel and meeting costs
- Equipment and minor equipment
- Data management and consultancy services
Ineligible Costs and Activities
- Pre-clinical therapy development studies
- Interventional clinical trials
- Projects focused only on excluded rare neurodegenerative diseases
- Rare infectious diseases and rare cancers
- Overheads for CIHR funding
Eligible geographic areas
- Canada
- Austria
- Belgium
- Bulgaria
- Czech Republic
- Cyprus
- Denmark
- Estonia
- France
- Germany
- Hungary
- Ireland
- Israel
- Italy
- Latvia
- Lithuania
- Luxembourg
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Spain
- Sweden
- The Netherlands
- Türkiye
Selection criteria
- Clarity and relevance of objectives
- Credibility of the approach and methodology
- Innovation and originality
- Capacity and expertise of the consortium
- Impact and patient benefit
How to apply
- Step 1: Prepare the pre-proposal
- Complete the pre-proposal form for ERDERA.
- Submit the pre-proposal online in English only.
- Step 2: Wait for invitation to the full proposal
- Only applicants explicitly invited by the Joint Call Secretariat may submit a full proposal.
- Step 3: Prepare the Canadian CIHR application, if applicable
- Canadian consortium members invited to the full proposal stage must complete an abbreviated CIHR application.
- Submit the CIHR application through ResearchNet in one of Canada’s two official languages.
- Step 4: Submit the full proposal to ERDERA
- Submit the full proposal to ERDERA in English only.
Processing and Agreement
- The pre-proposal is reviewed first, and only invited applicants can move to the full proposal stage.
- Canadian applications include a CIHR abbreviated application submitted through ResearchNet at the full proposal stage.
- Final funding decisions are made after the full proposal stage.
Additional information
- Funding is awarded through a two-stage transnational process.
- All funded partners must sign a consortium agreement.
- Open access is required for peer-reviewed publications.
- Annual and final reporting obligations apply.
Contacts
Frequently Asked Questions about the Team Grant: ERDERA Joint Transnational Call 2026 Program
What is the Team Grant: ERDERA Joint Transnational Call 2026?
This program supports international research on unresolved rare genetic and non-genetic diseases. The maximum funding is CAD 450,000 per grant for up to 3 years, and eligible activities include collaborative diagnostic research, data analysis, and related project work.
How much funding can be received?
Team Grant: ERDERA Joint Transnational Call 2026 Funds up to $450,000 of admissible expenses.
Who is eligible for the Team Grant: ERDERA Joint Transnational Call 2026 program?
To be eligible for the Team Grant: ERDERA Joint Transnational Call 2026 program, you must:
Independent Canadian lead researcher
Eligible Canadian host institution
Project must fit call scope
What expenses are eligible under Team Grant: ERDERA Joint Transnational Call 2026?
Diagnostic research on unresolved rare genetic diseases
Research on complex rare non-genetic diseases
Identification of causative variants in undiagnosed cases
Use of multi-omics, bioinformatics, AI, and systems biology approaches
Who can I contact for more information about the Team Grant: ERDERA Joint Transnational Call 2026?
You can contact Canadian Institutes of Health Research (CIHR) by email at ERDERAcall@agencerecherche.fr or by phone at 613-954-1968.
Where is the Team Grant: ERDERA Joint Transnational Call 2026 available?
The Team Grant: ERDERA Joint Transnational Call 2026 program is available across Canada.
Is the Team Grant: ERDERA Joint Transnational Call 2026 a grant, loan, or tax credit?
Team Grant: ERDERA Joint Transnational Call 2026 is a Partnering and Collaboration